CJC-1295 DAC

Full name: CJC-1295 with Drug Affinity Complex

A long-acting GHRH analogue that uses the Drug Affinity Complex (DAC) technology to bind covalently to albumin in the bloodstream, dramatically extending its half-life to approximately 6–8 days. Produces sustained elevation of GH and IGF-1 levels. Distinguished from CJC-1295 without DAC (also called Modified GRF 1-29) by its much longer duration of action.